Therachem Research Medilab (India) Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 25-07-2024
- Paid Up Capital ₹ 5.38 M
as on 25-07-2024
- Company Age 18 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.30 Cr
as on 25-07-2024
- Revenue -6.98%
(FY 2023)
- Profit -47.25%
(FY 2023)
- Ebitda -50.53%
(FY 2023)
- Net Worth -29.54%
(FY 2023)
- Total Assets -21.31%
(FY 2023)
About Therachem Research Medilab (India)
- CIN/LLPIN
U24232RJ2006PTC023466
- Company No.
023466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2006
- Date of AGM
02 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Therachem Research Medilab (India) Private Limited offer?
Therachem Research Medilab (India) Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Architectural & Civil Engineering, Civil Engineering Service, Engineering Consultant Service, Telecom Services, Engg & Maintenance, Telecom Engineering Services, Electrical Work, Power Transmission Services.
Who are the key members and board of directors at Therachem Research Medilab (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Dhaga  | Director | 02-Jun-2023 | Current |
| Rajnish Sarna | Director | 02-Jun-2023 | Current |
| Anil Jain | Director | 02-Jun-2023 | Current |
Financial Performance of Therachem Research Medilab (India).
Therachem Research Medilab (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.98% decrease. The company also saw a substantial fall in profitability, with a 47.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therachem Research Medilab (India)?
In 2023, Therachem Research Medilab (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jul 2016 | ₹3.00 Cr | Satisfied |
Punjab National Bank Creation Date: 02 Apr 2008 | ₹3.30 Cr | Satisfied |
How Many Employees Work at Therachem Research Medilab (India)?
Therachem Research Medilab (India) has a workforce of 118 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therachem Research Medilab (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therachem Research Medilab (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
